Jane Dewar

1.2k total citations
26 papers, 879 citations indexed

About

Jane Dewar is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Jane Dewar has authored 26 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Jane Dewar's work include Cystic Fibrosis Research Advances (12 papers), Asthma and respiratory diseases (7 papers) and Inhalation and Respiratory Drug Delivery (6 papers). Jane Dewar is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Asthma and respiratory diseases (7 papers) and Inhalation and Respiratory Drug Delivery (6 papers). Jane Dewar collaborates with scholars based in United Kingdom, United States and Switzerland. Jane Dewar's co-authors include Ian P. Hall, Brian J. Lipworth, Eleanor Dow, Amanda Wheatley, John R. Cockcroft, Joseph P. Noon, Anastasios Gazis, Neal J. Thomas, Stephen T. Holgate and Iolo Doull and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and CHEST Journal.

In The Last Decade

Jane Dewar

25 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Dewar United Kingdom 11 454 350 306 139 72 26 879
David Herion United States 15 88 0.2× 332 0.9× 77 0.3× 30 0.2× 42 0.6× 20 1.8k
A Mackiewicz United States 12 105 0.2× 336 1.0× 94 0.3× 34 0.2× 38 0.5× 21 1.2k
Naga S. Betrapally United States 12 289 0.6× 604 1.7× 28 0.1× 42 0.3× 39 0.5× 16 1.1k
Silva Kasela Estonia 13 178 0.4× 647 1.8× 35 0.1× 23 0.2× 49 0.7× 19 1.1k
Alison Severn United Kingdom 17 418 0.9× 200 0.6× 272 0.9× 11 0.1× 49 0.7× 29 1.5k
Luís Menchén Spain 20 123 0.3× 280 0.8× 54 0.2× 34 0.2× 28 0.4× 82 1.3k
Randy Taplitz United States 10 169 0.4× 145 0.4× 84 0.3× 20 0.1× 13 0.2× 18 1.3k
Derek A. Wong United States 20 61 0.1× 289 0.8× 49 0.2× 42 0.3× 46 0.6× 37 1.2k
R. Robert Vethanayagam United States 18 32 0.1× 282 0.8× 94 0.3× 48 0.3× 76 1.1× 20 1.0k

Countries citing papers authored by Jane Dewar

Since Specialization
Citations

This map shows the geographic impact of Jane Dewar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Dewar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Dewar more than expected).

Fields of papers citing papers by Jane Dewar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Dewar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Dewar. The network helps show where Jane Dewar may publish in the future.

Co-authorship network of co-authors of Jane Dewar

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Dewar. A scholar is included among the top collaborators of Jane Dewar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Dewar. Jane Dewar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hoo, Zhe Hui, F. Edenborough, Laura Prtak, et al.. (2018). Understanding Pseudomonas status among adults with cystic fibrosis: a real-world comparison of the Leeds criteria against clinicians’ decision. European Journal of Clinical Microbiology & Infectious Diseases. 37(4). 735–743. 14 indexed citations
3.
Hoo, Zhe Hui, Benjamin Gardner, Madelynne A Arden, et al.. (2018). Role of habit in treatment adherence among adults with cystic fibrosis. Thorax. 74(2). 197–199. 28 indexed citations
4.
Barr, H., Miguel Cámara, David A. Barrett, et al.. (2017). Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis. ERJ Open Research. 3(3). 57–2017. 1 indexed citations
5.
Hoo, Zhe Hui, Simon Waterhouse, Julia A. Nightingale, et al.. (2017). 155 CFHealthHub: using Leeds criteria and clinicians' decision to determine the pseudomonas status among the 64 adults with cystic fibrosis in the two centre CFHealthHub (CFHH) pilot study. Journal of Cystic Fibrosis. 16. S105–S106. 4 indexed citations
6.
7.
Barr, H., Nigel Halliday, David A. Barrett, et al.. (2016). Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study. Journal of Cystic Fibrosis. 16(2). 230–238. 29 indexed citations
8.
Barr, H., Nigel Halliday, Miguel Cámara, et al.. (2015). Pseudomonas aeruginosaquorum sensing molecules correlate with clinical status in cystic fibrosis. European Respiratory Journal. 46(4). 1046–1054. 85 indexed citations
9.
Forrester, Douglas L., Alan J. Knox, Alan R Smyth, et al.. (2015). Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial. Pediatric Pulmonology. 51(3). 253–257. 5 indexed citations
10.
11.
Dewar, Jane, et al.. (2014). Appetite stimulants for people with cystic fibrosis. Cochrane Database of Systematic Reviews. CD008190–CD008190. 23 indexed citations
12.
Dewar, Jane, et al.. (2013). 230 Barriers to exercise participation in adult CF patients. Journal of Cystic Fibrosis. 12. S107–S107. 1 indexed citations
13.
Hall, Ian P., Amanda Wheatley, & Jane Dewar. (2003). Genetic Polymorphisms of Adrenergic Receptors. Humana Press eBooks. 126. 117–126. 1 indexed citations
14.
Dewar, Jane & Ian P. Hall. (2003). Personalised prescribing for asthma - is pharmacogenetics the answer?. Journal of Pharmacy and Pharmacology. 55(3). 279–289. 11 indexed citations
15.
Heeke, Gino Van, Jean‐Yves Métais, John R. Fozard, et al.. (2002). Single Nucleotide Polymorphism analysis of the human adenosine A2B receptor gene: prevalence of SNPs in asthmatics and normal subjects. 3(3-4). 87–92. 3 indexed citations
16.
Cho, Seong, Ian P. Hall, Amanda Wheatley, et al.. (2001). Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma. Journal of Allergy and Clinical Immunology. 108(2). 212–214. 54 indexed citations
17.
Hopes, Elaine A., Catherine M. McDougall, G. L. CHRISTIE, et al.. (1998). Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. BMJ. 316(7132). 664–664. 68 indexed citations
18.
Dewar, Jane, Amanda Wheatley, Jane Wilkinson, et al.. (1997). Association of the Gln 27 β2-Adrenoceptor Polymorphism and IgE Variability in Asthmatic Families. CHEST Journal. 111(6). 78S–79S. 4 indexed citations
19.
Dewar, Jane, Jennifer Wilkinson, Amanda Wheatley, et al.. (1997). The glutamine 27 β2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. Journal of Allergy and Clinical Immunology. 100(2). 261–265. 128 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Herion Breakdown of academic impact, for papers by A Mackiewicz Breakdown of academic impact, for papers by Naga S. Betrapally Breakdown of academic impact, for papers by Silva Kasela Breakdown of academic impact, for papers by Alison Severn Breakdown of academic impact, for papers by Luís Menchén Breakdown of academic impact, for papers by Randy Taplitz Breakdown of academic impact, for papers by Derek A. Wong Breakdown of academic impact, for papers by R. Robert Vethanayagam
Rankless by CCL
2026